Global Drugs for Malaria Market Analysis and Forecast 2024-2030
Summary
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Drugs for Malaria, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs for Malaria, also provides the revenue of main regions and countries. Of the upcoming market potential for Drugs for Malaria, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Malaria revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Malaria market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Malaria revenue, projected growth trends, production technology, application and end-user industry.
Drugs for Malaria segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Drugs for Malaria in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Drugs for Malaria company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Malaria revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Drugs for Malaria, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs for Malaria, also provides the revenue of main regions and countries. Of the upcoming market potential for Drugs for Malaria, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Malaria revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Malaria market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Malaria revenue, projected growth trends, production technology, application and end-user industry.
Drugs for Malaria segment by Company
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Prevention
- Treatment
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Drugs for Malaria in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Drugs for Malaria company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Malaria revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Drugs for Malaria Market by Type
1.2.1 Global Drugs for Malaria Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Drugs for Malaria Market by Application
1.3.1 Global Drugs for Malaria Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DRUGS FOR MALARIA MARKET DYNAMICS
2.1 Drugs for Malaria Industry Trends
2.2 Drugs for Malaria Industry Drivers
2.3 Drugs for Malaria Industry Opportunities and Challenges
2.4 Drugs for Malaria Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Drugs for Malaria Market Perspective (2019-2030)
3.2 Global Drugs for Malaria Growth Trends by Region
3.2.1 Global Drugs for Malaria Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Drugs for Malaria Market Size by Region (2019-2024)
3.2.3 Global Drugs for Malaria Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Drugs for Malaria Revenue by Players
4.1.1 Global Drugs for Malaria Revenue by Players (2019-2024)
4.1.2 Global Drugs for Malaria Revenue Market Share by Players (2019-2024)
4.1.3 Global Drugs for Malaria Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Drugs for Malaria Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Drugs for Malaria Key Players Headquarters & Area Served
4.4 Global Drugs for Malaria Players, Product Type & Application
4.5 Global Drugs for Malaria Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Drugs for Malaria Market CR5 and HHI
4.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
4.6.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
5 DRUGS FOR MALARIA MARKET SIZE BY TYPE
5.1 Global Drugs for Malaria Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Drugs for Malaria Revenue by Type (2019-2030)
5.3 Global Drugs for Malaria Revenue Market Share by Type (2019-2030)
6 DRUGS FOR MALARIA MARKET SIZE BY APPLICATION
6.1 Global Drugs for Malaria Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Drugs for Malaria Revenue by Application (2019-2030)
6.3 Global Drugs for Malaria Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Cipla
7.1.1 Cipla Comapny Information
7.1.2 Cipla Business Overview
7.1.3 Cipla Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.1.4 Cipla Drugs for Malaria Product Portfolio
7.1.5 Cipla Recent Developments
7.2 Guilin Pharmaceutical
7.2.1 Guilin Pharmaceutical Comapny Information
7.2.2 Guilin Pharmaceutical Business Overview
7.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
7.2.5 Guilin Pharmaceutical Recent Developments
7.3 IPCA Laboratories
7.3.1 IPCA Laboratories Comapny Information
7.3.2 IPCA Laboratories Business Overview
7.3.3 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
7.3.5 IPCA Laboratories Recent Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Comapny Information
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
7.4.5 GlaxoSmithKline Recent Developments
7.5 Mylan Labs
7.5.1 Mylan Labs Comapny Information
7.5.2 Mylan Labs Business Overview
7.5.3 Mylan Labs Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.5.4 Mylan Labs Drugs for Malaria Product Portfolio
7.5.5 Mylan Labs Recent Developments
7.6 Roche
7.6.1 Roche Comapny Information
7.6.2 Roche Business Overview
7.6.3 Roche Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.6.4 Roche Drugs for Malaria Product Portfolio
7.6.5 Roche Recent Developments
7.7 Novartis
7.7.1 Novartis Comapny Information
7.7.2 Novartis Business Overview
7.7.3 Novartis Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.7.4 Novartis Drugs for Malaria Product Portfolio
7.7.5 Novartis Recent Developments
7.8 Sanofi Aventis
7.8.1 Sanofi Aventis Comapny Information
7.8.2 Sanofi Aventis Business Overview
7.8.3 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
7.8.5 Sanofi Aventis Recent Developments
7.9 Ajanta Pharma
7.9.1 Ajanta Pharma Comapny Information
7.9.2 Ajanta Pharma Business Overview
7.9.3 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
7.9.5 Ajanta Pharma Recent Developments
8 NORTH AMERICA
8.1 North America Drugs for Malaria Revenue (2019-2030)
8.2 North America Drugs for Malaria Revenue by Type (2019-2030)
8.2.1 North America Drugs for Malaria Revenue by Type (2019-2024)
8.2.2 North America Drugs for Malaria Revenue by Type (2025-2030)
8.3 North America Drugs for Malaria Revenue Share by Type (2019-2030)
8.4 North America Drugs for Malaria Revenue by Application (2019-2030)
8.4.1 North America Drugs for Malaria Revenue by Application (2019-2024)
8.4.2 North America Drugs for Malaria Revenue by Application (2025-2030)
8.5 North America Drugs for Malaria Revenue Share by Application (2019-2030)
8.6 North America Drugs for Malaria Revenue by Country
8.6.1 North America Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Drugs for Malaria Revenue by Country (2019-2024)
8.6.3 North America Drugs for Malaria Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Drugs for Malaria Revenue (2019-2030)
9.2 Europe Drugs for Malaria Revenue by Type (2019-2030)
9.2.1 Europe Drugs for Malaria Revenue by Type (2019-2024)
9.2.2 Europe Drugs for Malaria Revenue by Type (2025-2030)
9.3 Europe Drugs for Malaria Revenue Share by Type (2019-2030)
9.4 Europe Drugs for Malaria Revenue by Application (2019-2030)
9.4.1 Europe Drugs for Malaria Revenue by Application (2019-2024)
9.4.2 Europe Drugs for Malaria Revenue by Application (2025-2030)
9.5 Europe Drugs for Malaria Revenue Share by Application (2019-2030)
9.6 Europe Drugs for Malaria Revenue by Country
9.6.1 Europe Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Drugs for Malaria Revenue by Country (2019-2024)
9.6.3 Europe Drugs for Malaria Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Drugs for Malaria Revenue (2019-2030)
10.2 China Drugs for Malaria Revenue by Type (2019-2030)
10.2.1 China Drugs for Malaria Revenue by Type (2019-2024)
10.2.2 China Drugs for Malaria Revenue by Type (2025-2030)
10.3 China Drugs for Malaria Revenue Share by Type (2019-2030)
10.4 China Drugs for Malaria Revenue by Application (2019-2030)
10.4.1 China Drugs for Malaria Revenue by Application (2019-2024)
10.4.2 China Drugs for Malaria Revenue by Application (2025-2030)
10.5 China Drugs for Malaria Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Drugs for Malaria Revenue (2019-2030)
11.2 Asia Drugs for Malaria Revenue by Type (2019-2030)
11.2.1 Asia Drugs for Malaria Revenue by Type (2019-2024)
11.2.2 Asia Drugs for Malaria Revenue by Type (2025-2030)
11.3 Asia Drugs for Malaria Revenue Share by Type (2019-2030)
11.4 Asia Drugs for Malaria Revenue by Application (2019-2030)
11.4.1 Asia Drugs for Malaria Revenue by Application (2019-2024)
11.4.2 Asia Drugs for Malaria Revenue by Application (2025-2030)
11.5 Asia Drugs for Malaria Revenue Share by Application (2019-2030)
11.6 Asia Drugs for Malaria Revenue by Country
11.6.1 Asia Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Drugs for Malaria Revenue by Country (2019-2024)
11.6.3 Asia Drugs for Malaria Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Drugs for Malaria Revenue (2019-2030)
12.2 MEALA Drugs for Malaria Revenue by Type (2019-2030)
12.2.1 MEALA Drugs for Malaria Revenue by Type (2019-2024)
12.2.2 MEALA Drugs for Malaria Revenue by Type (2025-2030)
12.3 MEALA Drugs for Malaria Revenue Share by Type (2019-2030)
12.4 MEALA Drugs for Malaria Revenue by Application (2019-2030)
12.4.1 MEALA Drugs for Malaria Revenue by Application (2019-2024)
12.4.2 MEALA Drugs for Malaria Revenue by Application (2025-2030)
12.5 MEALA Drugs for Malaria Revenue Share by Application (2019-2030)
12.6 MEALA Drugs for Malaria Revenue by Country
12.6.1 MEALA Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Drugs for Malaria Revenue by Country (2019-2024)
12.6.3 MEALA Drugs for Malaria Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Drugs for Malaria Market by Type
1.2.1 Global Drugs for Malaria Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Drugs for Malaria Market by Application
1.3.1 Global Drugs for Malaria Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DRUGS FOR MALARIA MARKET DYNAMICS
2.1 Drugs for Malaria Industry Trends
2.2 Drugs for Malaria Industry Drivers
2.3 Drugs for Malaria Industry Opportunities and Challenges
2.4 Drugs for Malaria Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Drugs for Malaria Market Perspective (2019-2030)
3.2 Global Drugs for Malaria Growth Trends by Region
3.2.1 Global Drugs for Malaria Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Drugs for Malaria Market Size by Region (2019-2024)
3.2.3 Global Drugs for Malaria Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Drugs for Malaria Revenue by Players
4.1.1 Global Drugs for Malaria Revenue by Players (2019-2024)
4.1.2 Global Drugs for Malaria Revenue Market Share by Players (2019-2024)
4.1.3 Global Drugs for Malaria Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Drugs for Malaria Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Drugs for Malaria Key Players Headquarters & Area Served
4.4 Global Drugs for Malaria Players, Product Type & Application
4.5 Global Drugs for Malaria Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Drugs for Malaria Market CR5 and HHI
4.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
4.6.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
5 DRUGS FOR MALARIA MARKET SIZE BY TYPE
5.1 Global Drugs for Malaria Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Drugs for Malaria Revenue by Type (2019-2030)
5.3 Global Drugs for Malaria Revenue Market Share by Type (2019-2030)
6 DRUGS FOR MALARIA MARKET SIZE BY APPLICATION
6.1 Global Drugs for Malaria Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Drugs for Malaria Revenue by Application (2019-2030)
6.3 Global Drugs for Malaria Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Cipla
7.1.1 Cipla Comapny Information
7.1.2 Cipla Business Overview
7.1.3 Cipla Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.1.4 Cipla Drugs for Malaria Product Portfolio
7.1.5 Cipla Recent Developments
7.2 Guilin Pharmaceutical
7.2.1 Guilin Pharmaceutical Comapny Information
7.2.2 Guilin Pharmaceutical Business Overview
7.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
7.2.5 Guilin Pharmaceutical Recent Developments
7.3 IPCA Laboratories
7.3.1 IPCA Laboratories Comapny Information
7.3.2 IPCA Laboratories Business Overview
7.3.3 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
7.3.5 IPCA Laboratories Recent Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Comapny Information
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
7.4.5 GlaxoSmithKline Recent Developments
7.5 Mylan Labs
7.5.1 Mylan Labs Comapny Information
7.5.2 Mylan Labs Business Overview
7.5.3 Mylan Labs Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.5.4 Mylan Labs Drugs for Malaria Product Portfolio
7.5.5 Mylan Labs Recent Developments
7.6 Roche
7.6.1 Roche Comapny Information
7.6.2 Roche Business Overview
7.6.3 Roche Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.6.4 Roche Drugs for Malaria Product Portfolio
7.6.5 Roche Recent Developments
7.7 Novartis
7.7.1 Novartis Comapny Information
7.7.2 Novartis Business Overview
7.7.3 Novartis Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.7.4 Novartis Drugs for Malaria Product Portfolio
7.7.5 Novartis Recent Developments
7.8 Sanofi Aventis
7.8.1 Sanofi Aventis Comapny Information
7.8.2 Sanofi Aventis Business Overview
7.8.3 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
7.8.5 Sanofi Aventis Recent Developments
7.9 Ajanta Pharma
7.9.1 Ajanta Pharma Comapny Information
7.9.2 Ajanta Pharma Business Overview
7.9.3 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (2019-2024)
7.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
7.9.5 Ajanta Pharma Recent Developments
8 NORTH AMERICA
8.1 North America Drugs for Malaria Revenue (2019-2030)
8.2 North America Drugs for Malaria Revenue by Type (2019-2030)
8.2.1 North America Drugs for Malaria Revenue by Type (2019-2024)
8.2.2 North America Drugs for Malaria Revenue by Type (2025-2030)
8.3 North America Drugs for Malaria Revenue Share by Type (2019-2030)
8.4 North America Drugs for Malaria Revenue by Application (2019-2030)
8.4.1 North America Drugs for Malaria Revenue by Application (2019-2024)
8.4.2 North America Drugs for Malaria Revenue by Application (2025-2030)
8.5 North America Drugs for Malaria Revenue Share by Application (2019-2030)
8.6 North America Drugs for Malaria Revenue by Country
8.6.1 North America Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Drugs for Malaria Revenue by Country (2019-2024)
8.6.3 North America Drugs for Malaria Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Drugs for Malaria Revenue (2019-2030)
9.2 Europe Drugs for Malaria Revenue by Type (2019-2030)
9.2.1 Europe Drugs for Malaria Revenue by Type (2019-2024)
9.2.2 Europe Drugs for Malaria Revenue by Type (2025-2030)
9.3 Europe Drugs for Malaria Revenue Share by Type (2019-2030)
9.4 Europe Drugs for Malaria Revenue by Application (2019-2030)
9.4.1 Europe Drugs for Malaria Revenue by Application (2019-2024)
9.4.2 Europe Drugs for Malaria Revenue by Application (2025-2030)
9.5 Europe Drugs for Malaria Revenue Share by Application (2019-2030)
9.6 Europe Drugs for Malaria Revenue by Country
9.6.1 Europe Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Drugs for Malaria Revenue by Country (2019-2024)
9.6.3 Europe Drugs for Malaria Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Drugs for Malaria Revenue (2019-2030)
10.2 China Drugs for Malaria Revenue by Type (2019-2030)
10.2.1 China Drugs for Malaria Revenue by Type (2019-2024)
10.2.2 China Drugs for Malaria Revenue by Type (2025-2030)
10.3 China Drugs for Malaria Revenue Share by Type (2019-2030)
10.4 China Drugs for Malaria Revenue by Application (2019-2030)
10.4.1 China Drugs for Malaria Revenue by Application (2019-2024)
10.4.2 China Drugs for Malaria Revenue by Application (2025-2030)
10.5 China Drugs for Malaria Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Drugs for Malaria Revenue (2019-2030)
11.2 Asia Drugs for Malaria Revenue by Type (2019-2030)
11.2.1 Asia Drugs for Malaria Revenue by Type (2019-2024)
11.2.2 Asia Drugs for Malaria Revenue by Type (2025-2030)
11.3 Asia Drugs for Malaria Revenue Share by Type (2019-2030)
11.4 Asia Drugs for Malaria Revenue by Application (2019-2030)
11.4.1 Asia Drugs for Malaria Revenue by Application (2019-2024)
11.4.2 Asia Drugs for Malaria Revenue by Application (2025-2030)
11.5 Asia Drugs for Malaria Revenue Share by Application (2019-2030)
11.6 Asia Drugs for Malaria Revenue by Country
11.6.1 Asia Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Drugs for Malaria Revenue by Country (2019-2024)
11.6.3 Asia Drugs for Malaria Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Drugs for Malaria Revenue (2019-2030)
12.2 MEALA Drugs for Malaria Revenue by Type (2019-2030)
12.2.1 MEALA Drugs for Malaria Revenue by Type (2019-2024)
12.2.2 MEALA Drugs for Malaria Revenue by Type (2025-2030)
12.3 MEALA Drugs for Malaria Revenue Share by Type (2019-2030)
12.4 MEALA Drugs for Malaria Revenue by Application (2019-2030)
12.4.1 MEALA Drugs for Malaria Revenue by Application (2019-2024)
12.4.2 MEALA Drugs for Malaria Revenue by Application (2025-2030)
12.5 MEALA Drugs for Malaria Revenue Share by Application (2019-2030)
12.6 MEALA Drugs for Malaria Revenue by Country
12.6.1 MEALA Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Drugs for Malaria Revenue by Country (2019-2024)
12.6.3 MEALA Drugs for Malaria Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Aryl Aminoalcohol Compounds Major Manufacturers
Table 2. Antifolate Compounds Major Manufacturers
Table 3. Artemisinin Compounds Major Manufacturers
Table 4. Global Drugs for Malaria Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Prevention Major Manufacturers
Table 6. Treatment Major Manufacturers
Table 7. Others Major Manufacturers
Table 8. Drugs for Malaria Industry Trends
Table 9. Drugs for Malaria Industry Drivers
Table 10. Drugs for Malaria Industry Opportunities and Challenges
Table 11. Drugs for Malaria Industry Restraints
Table 12. Global Drugs for Malaria Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Drugs for Malaria Market Share by Region (2019-2024)
Table 15. Global Drugs for Malaria Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Drugs for Malaria Market Share by Region (2025-2030)
Table 17. Global Drugs for Malaria Revenue by Players (US$ Million) & (2019-2024)
Table 18. Global Drugs for Malaria Revenue Market Share by Players (2019-2024)
Table 19. Global Drugs for Malaria Key Players Ranking, 2022 VS 2023 VS 2024
Table 20. Global Drugs for Malaria Key Players Headquarters & Area Served
Table 21. Global Drugs for Malaria Players, Product Type & Application
Table 22. Global Drugs for Malaria Players Commercialization Time
Table 23. Global Players Market Concentration Ratio (CR5 and HHI)
Table 24. Global Drugs for Malaria by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 25. Global Drugs for Malaria Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 27. Global Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Table 28. Global Drugs for Malaria Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 29. Global Drugs for Malaria Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 30. Global Drugs for Malaria Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 32. Global Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Table 33. Global Drugs for Malaria Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 34. Global Drugs for Malaria Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 35. Cipla Company Information
Table 36. Cipla Business Overview
Table 37. Cipla Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 38. Cipla Drugs for Malaria Product Portfolio
Table 39. Cipla Recent Development
Table 40. Guilin Pharmaceutical Company Information
Table 41. Guilin Pharmaceutical Business Overview
Table 42. Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 44. Guilin Pharmaceutical Recent Development
Table 45. IPCA Laboratories Company Information
Table 46. IPCA Laboratories Business Overview
Table 47. IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 49. IPCA Laboratories Recent Development
Table 50. GlaxoSmithKline Company Information
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 54. GlaxoSmithKline Recent Development
Table 55. Mylan Labs Company Information
Table 56. Mylan Labs Business Overview
Table 57. Mylan Labs Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Mylan Labs Drugs for Malaria Product Portfolio
Table 59. Mylan Labs Recent Development
Table 60. Roche Company Information
Table 61. Roche Business Overview
Table 62. Roche Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. Roche Drugs for Malaria Product Portfolio
Table 64. Roche Recent Development
Table 65. Novartis Company Information
Table 66. Novartis Business Overview
Table 67. Novartis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. Novartis Drugs for Malaria Product Portfolio
Table 69. Novartis Recent Development
Table 70. Sanofi Aventis Company Information
Table 71. Sanofi Aventis Business Overview
Table 72. Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 74. Sanofi Aventis Recent Development
Table 75. Ajanta Pharma Company Information
Table 76. Ajanta Pharma Business Overview
Table 77. Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 79. Ajanta Pharma Recent Development
Table 80. North America Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 81. North America Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 82. North America Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 83. North America Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 84. North America Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 85. Europe Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 86. Europe Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 87. Europe Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 88. Europe Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 89. Europe Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 90. China Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 91. China Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 92. Asia Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 93. Asia Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 94. Asia Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 95. Asia Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 96. Asia Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 97. MEALA Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 98. MEALA Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 99. MEALA Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 100. MEALA Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 101. MEALA Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 102. Research Programs/Design for This Report
Table 103. Authors List of This Report
Table 104. Secondary Sources
Table 105. Primary Sources
Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Aryl Aminoalcohol Compounds Major Manufacturers
Table 2. Antifolate Compounds Major Manufacturers
Table 3. Artemisinin Compounds Major Manufacturers
Table 4. Global Drugs for Malaria Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Prevention Major Manufacturers
Table 6. Treatment Major Manufacturers
Table 7. Others Major Manufacturers
Table 8. Drugs for Malaria Industry Trends
Table 9. Drugs for Malaria Industry Drivers
Table 10. Drugs for Malaria Industry Opportunities and Challenges
Table 11. Drugs for Malaria Industry Restraints
Table 12. Global Drugs for Malaria Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Drugs for Malaria Market Share by Region (2019-2024)
Table 15. Global Drugs for Malaria Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Drugs for Malaria Market Share by Region (2025-2030)
Table 17. Global Drugs for Malaria Revenue by Players (US$ Million) & (2019-2024)
Table 18. Global Drugs for Malaria Revenue Market Share by Players (2019-2024)
Table 19. Global Drugs for Malaria Key Players Ranking, 2022 VS 2023 VS 2024
Table 20. Global Drugs for Malaria Key Players Headquarters & Area Served
Table 21. Global Drugs for Malaria Players, Product Type & Application
Table 22. Global Drugs for Malaria Players Commercialization Time
Table 23. Global Players Market Concentration Ratio (CR5 and HHI)
Table 24. Global Drugs for Malaria by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 25. Global Drugs for Malaria Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 27. Global Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Table 28. Global Drugs for Malaria Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 29. Global Drugs for Malaria Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 30. Global Drugs for Malaria Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 32. Global Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Table 33. Global Drugs for Malaria Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 34. Global Drugs for Malaria Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 35. Cipla Company Information
Table 36. Cipla Business Overview
Table 37. Cipla Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 38. Cipla Drugs for Malaria Product Portfolio
Table 39. Cipla Recent Development
Table 40. Guilin Pharmaceutical Company Information
Table 41. Guilin Pharmaceutical Business Overview
Table 42. Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 44. Guilin Pharmaceutical Recent Development
Table 45. IPCA Laboratories Company Information
Table 46. IPCA Laboratories Business Overview
Table 47. IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 49. IPCA Laboratories Recent Development
Table 50. GlaxoSmithKline Company Information
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 54. GlaxoSmithKline Recent Development
Table 55. Mylan Labs Company Information
Table 56. Mylan Labs Business Overview
Table 57. Mylan Labs Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Mylan Labs Drugs for Malaria Product Portfolio
Table 59. Mylan Labs Recent Development
Table 60. Roche Company Information
Table 61. Roche Business Overview
Table 62. Roche Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. Roche Drugs for Malaria Product Portfolio
Table 64. Roche Recent Development
Table 65. Novartis Company Information
Table 66. Novartis Business Overview
Table 67. Novartis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. Novartis Drugs for Malaria Product Portfolio
Table 69. Novartis Recent Development
Table 70. Sanofi Aventis Company Information
Table 71. Sanofi Aventis Business Overview
Table 72. Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 74. Sanofi Aventis Recent Development
Table 75. Ajanta Pharma Company Information
Table 76. Ajanta Pharma Business Overview
Table 77. Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 79. Ajanta Pharma Recent Development
Table 80. North America Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 81. North America Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 82. North America Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 83. North America Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 84. North America Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 85. Europe Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 86. Europe Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 87. Europe Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 88. Europe Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 89. Europe Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 90. China Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 91. China Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 92. Asia Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 93. Asia Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 94. Asia Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 95. Asia Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 96. Asia Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 97. MEALA Drugs for Malaria Revenue by Type (2019-2024) & (US$ Million)
Table 98. MEALA Drugs for Malaria Revenue by Application (2019-2024) & (US$ Million)
Table 99. MEALA Drugs for Malaria Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 100. MEALA Drugs for Malaria Revenue by Country (2019-2024) & (US$ Million)
Table 101. MEALA Drugs for Malaria Revenue by Country (2025-2030) & (US$ Million)
Table 102. Research Programs/Design for This Report
Table 103. Authors List of This Report
Table 104. Secondary Sources
Table 105. Primary Sources
LIST OF FIGURES
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Malaria Market Size Share 2019 VS 2023 VS 2030
Figure 4. Aryl Aminoalcohol Compounds Picture
Figure 5. Antifolate Compounds Picture
Figure 6. Artemisinin Compounds Picture
Figure 7. Global Drugs for Malaria Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Drugs for Malaria Market Size Share 2019 VS 2023 VS 2030
Figure 9. Prevention Picture
Figure 10. Treatment Picture
Figure 11. Others Picture
Figure 12. Global Drugs for Malaria Market Size (US$ Million) & (2019-2030)
Figure 13. Global Drugs for Malaria Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drugs for Malaria Market Share by Region: 2019 VS 2023 VS 2030
Figure 15. Global Drugs for Malaria Players Revenue Share Top 10 and Top 5 in 2023
Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 17. Global Drugs for Malaria Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Drugs for Malaria Revenue Market Share 2019 VS 2023 VS 2030
Figure 19. Global Drugs for Malaria Revenue Market Share by Type (2019-2030)
Figure 20. Global Drugs for Malaria Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Drugs for Malaria Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 22. Global Drugs for Malaria Revenue Market Share by Application (2019-2030)
Figure 23. North America Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 25. North America Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 26. North America Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 27. North America Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 28. North America Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 29. United States Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Canada Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Europe Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 33. Europe Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 34. Europe Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 35. Europe Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 36. Europe Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 37. Germany Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. France Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. U.K. Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Italy Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Russia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Nordic Countries Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. China Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 45. China Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 46. China Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 47. China Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 48. Asia Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 49. Asia Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 50. Asia Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 51. Asia Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 52. Asia Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 53. Asia Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 54. Japan Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. South Korea Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. India Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Australia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. China Taiwan Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Southeast Asia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. MEALA Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 61. MEALA Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 62. MEALA Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 63. MEALA Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 64. MEALA Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 65. MEALA Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 66. Mexico Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. South Korea Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Brazil Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Israel Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Argentina Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Colombia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Turkey Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Saudi Arabia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. UAE Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Malaria Market Size Share 2019 VS 2023 VS 2030
Figure 4. Aryl Aminoalcohol Compounds Picture
Figure 5. Antifolate Compounds Picture
Figure 6. Artemisinin Compounds Picture
Figure 7. Global Drugs for Malaria Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Drugs for Malaria Market Size Share 2019 VS 2023 VS 2030
Figure 9. Prevention Picture
Figure 10. Treatment Picture
Figure 11. Others Picture
Figure 12. Global Drugs for Malaria Market Size (US$ Million) & (2019-2030)
Figure 13. Global Drugs for Malaria Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drugs for Malaria Market Share by Region: 2019 VS 2023 VS 2030
Figure 15. Global Drugs for Malaria Players Revenue Share Top 10 and Top 5 in 2023
Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 17. Global Drugs for Malaria Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Drugs for Malaria Revenue Market Share 2019 VS 2023 VS 2030
Figure 19. Global Drugs for Malaria Revenue Market Share by Type (2019-2030)
Figure 20. Global Drugs for Malaria Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Drugs for Malaria Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 22. Global Drugs for Malaria Revenue Market Share by Application (2019-2030)
Figure 23. North America Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 25. North America Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 26. North America Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 27. North America Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 28. North America Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 29. United States Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Canada Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Europe Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 33. Europe Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 34. Europe Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 35. Europe Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 36. Europe Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 37. Germany Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. France Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. U.K. Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Italy Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Russia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Nordic Countries Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. China Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 45. China Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 46. China Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 47. China Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 48. Asia Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 49. Asia Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 50. Asia Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 51. Asia Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 52. Asia Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 53. Asia Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 54. Japan Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. South Korea Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. India Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Australia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. China Taiwan Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Southeast Asia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. MEALA Drugs for Malaria Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 61. MEALA Drugs for Malaria Revenue by Type (2025-2030) & (US$ Million)
Figure 62. MEALA Drugs for Malaria Revenue Share by Type (2019-2030)
Figure 63. MEALA Drugs for Malaria Revenue by Application (2025-2030) & (US$ Million)
Figure 64. MEALA Drugs for Malaria Revenue Share by Application (2019-2030)
Figure 65. MEALA Drugs for Malaria Revenue Share by Country (2019-2030)
Figure 66. Mexico Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. South Korea Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Brazil Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Israel Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Argentina Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Colombia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Turkey Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Saudi Arabia Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. UAE Drugs for Malaria Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
